Fibrinogen recovery and changes in fibrin-based clot firmness after cryoprecipitate administration in patients undergoing aortic surgery involving deep hypothermic circulatory arrest

Transfusion

Volumn 54, Issue 5, 2014, Pages 1379-1387

  Lee, Sang Hyun ^a,b   Lee, Sangmin M ^b   Kim, Chung Su ^b   Cho, Hyun Sung ^b   Lee, Jong Hwan ^b   Lee, Cheol Hee ^b   Kim, Eunhee ^b   Sung, Kiick ^b   Solomon, Cristina ^c,d   Kang, Jingu ^a   Kim, Young Ri ^a  

^a Hallym University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c SALK University Hospital   (Austria)

^d CSL BEHRING GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FIBRINOGEN; PROTAMINE;

ADULT; AORTA ANEURYSM; AORTA DISSECTION; AORTA SURGERY; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CRYOPRECIPITATE; CRYOPRECIPITATE TRANSFUSION; DEEP HYPOTHERMIC CIRCULATORY ARREST; FEMALE; FIBRIN CLOT; FIBRINOGEN BLOOD LEVEL; HEMATOCRIT; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; MALE; MIDDLE AGED; OPERATIVE BLOOD LOSS; PROSPECTIVE STUDY; REOPERATION; THROMBOELASTOGRAPH; THROMBOELASTOGRAPHY;

ADULT; AGED; AORTA; BLOOD COAGULATION; CIRCULATORY ARREST, DEEP HYPOTHERMIA INDUCED; FACTOR VIII; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THROMBELASTOGRAPHY;

EID: 84900495471     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12479     Document Type: Article

References (45)

1. Despotis GJ, Joist JH, Goodnough LT,. Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. Clin Chem 1997; 43: 1684-1696.
2. Levy JH, Tanaka KA,. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003; 75: S715-720. (Pubitemid 36184553)
3. Solomon C, Rahe-Meyer N, Sorensen B,. Fibrin formation is more impaired than thrombin generation and platelets immediately following cardiac surgery. Thromb Res 2011; 128: 277-282.
4. Karlsson M, Ternstrom L, Hyllner M, et al. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: A prospective observational study. Transfusion 2008; 48: 2152-2158.
5. Anderson MA, Glazebrook B, Cutts B, et al. When do we transfuse cryoprecipitate? Intern Med J 2013; 43: 896-902.
6. Callum JL, Karkouti K, Lin Y,. Cryoprecipitate: the current state of knowledge. Transfus Med Rev 2009; 23: 177-188.
7. Sorensen B, Bevan D,. A critical evaluation of cryoprecipitate for replacement of fibrinogen. Br J Haematol 2010; 149: 834-843.
8. Yang L, Stanworth S, Baglin T,. Cryoprecipitate: An outmoded treatment? Transfus Med 2012; 22: 315-320.
9. Tomita Y, Shimode N, Ide T, et al. [Efficacy of cryoprecipitate transfusion for coagulopathy after cardiopulmonary bypass in thoracic aortic surgery]. Masui 2011; 60: 830-834.
10. Rahe-Meyer N, Hanke A, Schmidt DS, et al. Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial. J Thorac Cardiovasc Surg 2013; 145: S178-185.
11. Rahe-Meyer N, Solomon C, Hanke A, et al. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: A randomized, placebo-controlled trial. Anesthesiology 2013; 118: 40-50.
12. CSL Behring. Study of fibrinogen concentrate (human) (FCH) to control bleeding during complex cardiovascular surgery (REPLACE). ClinicalTrials.gov; 2013. [cited 2013 Jul 25]. Available from: http://www.clinicaltrials.gov/ct2/ show/NCT01475669?term=fibrinogen+concentrate&rank=4
13. Lang T, Johanning K, Metzler H, et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg 2009; 108: 751-758.
14. Rahe-Meyer N, Pichlmaier M, Haverich A, et al. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: A pilot study. Br J Anaesth 2009; 102: 785-792.
15. Weber CF, Gorlinger K, Meininger D, et al. Point-of-care testing: A prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117: 531-547.
16. Gorlinger K, Dirkmann D, Hanke AA, et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: A retrospective, single-center cohort study. Anesthesiology 2011; 115: 1179-1191.
17. Reinhofer M, Brauer M, Franke U, et al. The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass. Blood Coagul Fibrinolysis 2008; 19: 212-219. (Pubitemid 351498725)
18. Westbrook AJ, Olsen J, Bailey M, et al. Protocol based on thromboelastograph (TEG) out-performs physician preference using laboratory coagulation tests to guide blood replacement during and after cardiac surgery: A pilot study. Heart Lung Circ 2009; 18: 277-288.
19. Spalding GJ, Hartrumpf M, Sierig T, et al. Cost reduction of perioperative coagulation management in cardiac surgery: value of "bedside" thrombelastography (ROTEM). Eur J Cardiothorac Surg 2007; 31: 1052-1057. (Pubitemid 46719967)
20. Ak K, Isbir CS, Tetik S, et al. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: A prospective randomized study. J Card Surg 2009; 24: 404-410.
21. Girdauskas E, Kempfert J, Kuntze T, et al. Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: A prospective, randomized trial. J Thorac Cardiovasc Surg 2010; 140: 1117-1242.
22. Lee SH, Lee SM, Kim CS, et al. Use of fibrin-based thromboelastometry for cryoprecipitate transfusion in cardiac surgery involving deep hypothermic circulatory arrest during cardiopulmonary bypass. Blood Coagul Fibrinolysis 2010; 21: 687-691.
23. Solomon C, Pichlmaier U, Schoechl H, et al. Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. Br J Anaesth 2010; 104: 555-562.
24. Cardigan R, Philpot K, Cookson P, et al. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate. Transfusion 2009; 49: 696-703.
25. Caudill JS, Nichols WL, Plumhoff EA, et al. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma. Transfusion 2009; 49: 765-770.
26. Cid J, Caballo C, Pino M, et al. Quantitative and qualitative analysis of coagulation factors in cryoprecipitate prepared from fresh-frozen plasma inactivated with amotosalen and ultraviolet A light. Transfusion 2013; 53: 600-605.
27. Stinger HK, Spinella PC, Perkins JG, et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008; 64: S79-85.
28. Ketchum L, Hess JR, Hiippala S,. Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in trauma. J Trauma 2006; 60: S51-58.
29. Alport EC, Callum JL, Nahirniak S, et al. Cryoprecipitate use in 25 Canadian hospitals: commonly used outside of the published guidelines. Transfusion 2008; 48: 2122-2127.
30. Hattersley PG, Dimick ML,. Cryoprecipitates in treatment of congenital fibrinogen deficiency. Case report. Transfusion 1969; 9: 261-264.
31. Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists. JAMA 1994; 271: 777-781.
32. Puget Sound Blood Center. Blood component therapy. 2013. [cited 2013 Jul 25]. Available from: http://www.psbc.org/therapy/cryo.htm
33. Nascimento B, Rizoli S, Rubenfeld G, et al. Cryoprecipitate transfusion: Assessing appropriateness and dosing in trauma. Transfus Med 2011; 21: 394-401.
34. Kreuz W, Meili E, Peter-Salonen K, et al. Pharmacokinetic properties of a pasteurised fibrinogen concentrate. Transfus Apher Sci 2005; 32: 239-246. (Pubitemid 40804614)
35. Manco-Johnson MJ, Dimichele D, Castaman G, et al. Pharmacokinetics and safety of fibrinogen concentrate. J Thromb Haemost 2009; 7: 2064-2069.
36. Theusinger OM, Baulig W, Asmis LM, et al. In vitro factor XIII supplementation increases clot firmness in rotation thromboelastometry (ROTEM). Thromb Haemost 2010; 104: 385-391.
37. Luddington RJ,. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27: 81-90. (Pubitemid 40515992)
38. Dirkmann D, Gorlinger K, Dusse F, et al. Early thromboelastometric variables reliably predict maximum clot firmness in patients undergoing cardiac surgery: A step towards earlier decision making. Acta Anaesthesiol Scand 2013; 57: 594-603.
39. Ogawa S, Szlam F, Chen EP, et al. A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery. Transfusion 2012; 52: 14-22.
40. Romlin BS, Wahlander H, Synnergren M, et al. Earlier detection of coagulopathy with thromboelastometry during pediatric cardiac surgery: A prospective observational study. Paediatr Anaesth 2013; 23: 222-227.
41. Solomon C, Cadamuro J, Ziegler B, et al. A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients. Transfusion 2011; 51: 1695-1706.
42. Schlimp CJ, Solomon C, Hochleitner G, et al. Thromboelastometric maximum clot firmness in platelet-free plasma is influenced by the assay used. Anesth Analg 2013; 117: 23-29.
43. Solomon C, Rahe-Meyer N, Schochl H, et al. Effect of haematocrit on fibrin-based clot firmness in the FIBTEM test. Blood Transfus 2013; 11: 412-418.
44. Sniecinski RM, Chen EP, Tanaka KA,. Reduced levels of fibrin (antithrombin I) and antithrombin III underlie coagulopathy following complex cardiac surgery. Blood Coagul Fibrinolysis 2008; 19: 178-179. (Pubitemid 351252997)
45. Caballo C, Escolar G, Diaz-Ricart M, et al. Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentrates. Blood Transfus 2013; 11: 391-399.